 NEW YORK, Aug. 29, 2021 PRNewswire -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Orphazyme AS NASDAQ: ORPH: 1 pursuant andor traceable to Orphazymes September 29, 2020 initial public offering the IPO or Offering; andor 2 between September 29, 2020 and June 18, 2021, inclusive, the Class Period of the important September 7, 2021 lead plaintiff deadline in the securities class action. SO WHAT: If you purchased Orphazyme securities pursuant andor traceable to the IPO andor Orphazyme securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. 